Related Experiment Videos
Corneal anesthesia after timolol maleate therapy
American Journal of Ophthalmology
|October 1, 1979
Summary
Timolol maleate, a glaucoma medication, can cause superficial punctate keratitis and corneal anesthesia in susceptible patients. Discontinuing the drug often resolves these side effects and restores corneal sensitivity.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Glaucoma management often involves topical medications like timolol maleate.
- Understanding the ocular side effects of long-term glaucoma drug use is crucial for patient care.
Observation:
- Three patients developed symptomatic superficial punctate keratitis and complete corneal anesthesia.
- These symptoms occurred after prolonged use of timolol maleate for glaucoma.
Findings:
- Discontinuation of timolol maleate and switching to alternative glaucoma treatments led to gradual resolution of keratitis.
- Corneal sensitivity was markedly diminished in four elderly patients using timolol maleate for over three months.
- Timolol maleate exhibits local anesthetic properties in the human cornea after chronic use in susceptible individuals.
Implications:
- Clinicians should be aware of the potential for corneal anesthesia and keratitis with chronic timolol maleate use.
- Regular monitoring of corneal sensitivity may be warranted in elderly patients on long-term timolol maleate therapy.
- This finding suggests a need for further research into the neurotoxic effects of topical beta-blockers on the cornea.